A Kunitz-type Protease Inhibitor, Bikunin, Inhibits Ovarian Cancer Cell Invasion by Blocking the Calcium-dependent Transforming Growth Factor-β1 Signaling Cascade

This publication has 32 references indexed in Scilit:

• Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal‐regulated kinase‐dependent cascade
  European Journal of Biochemistry, 2002
• Suppression of Urokinase Expression and Invasiveness by Urinary Trypsin Inhibitor Is Mediated through Inhibition of Protein Kinase C- and MEK/ERK/c-Jun-dependent Signaling Pathways
  Published by Elsevier ,2001
• Osteoblast-derived TGF-β1 modulates matrix degrading protease expression and activity in prostate cancer cells
  International Journal of Cancer, 2000
• Urinary trypsin inhibitor suppresses vascular smooth muscle contraction by inhibition of Ca2+ influx
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1998
• Thrombospondin-1 and transforming growth factor-betal promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system
  Surgery, 1997
• Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent
  British Journal of Cancer, 1995
• Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells
  Cancer, 1995
• Down-Regulation of Interleukin-8 Gene Expression in HL60 Cell Line by Human Kunitz-Type Trypsin Inhibitor
  Biochemical and Biophysical Research Communications, 1995
• Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?
  Trends in Pharmacological Sciences, 1994
• Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis
  Cancer and Metastasis Reviews, 1990